C-Further is a new drug discovery initiative dedicated to accelerating the discovery of tailored therapeutics for children with cancer. Backed by a $50m investment, we provide expertise, capabilities and access to a broad network of scientific leaders and partners to help advance promising research towards patient benefit. Our founding organisations have contributed to the development of +20 approved medicines.

We are currently inviting researchers worldwide to submit project proposals or connect with us informally to explore potential collaboration opportunities. We will also be hosting a webinar in mid-July ahead of our next application deadline on 4 September 2026.

More information: www.c-further.org/work-with-us/researchers